1,255
Views
44
CrossRef citations to date
0
Altmetric
Articles

Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users

, M.Sc., , M.Sc., , B.Sc., , B.Sc., , M.Sc., , Ph.D. ORCID Icon, , Ph.D., , Ph.D. & , Ph.D. ORCID Icon show all
Pages 135-145 | Received 26 Nov 2018, Accepted 12 Dec 2018, Published online: 07 Feb 2019

References

  • 5alDía. 2018. Accessed October 23, 2018. http://www.5aldia.org/contenido-s.php?ro=931&sm=1187à11239&co=7562&pg=1.
  • Andritzky, W. 1989. Sociopsychotherapeutic functions of ayahuasca healing in Amazonia. Journal of Psychoactive Drugs 21 (1):77–89. doi:10.1080/02791072.1989.10472145.
  • AOMM. 2014. Primer estudio sobre la práctica de Yoga en España. Accessed October 23, 2018. https://docplayer.es/7704874-Primer-estudio-sobre-la-practica-de-yoga-en-espana.html.
  • Apud, I., and O. Romaní. 2017. Medicine, religion and ayahuasca in Catalonia. Considering ayahuasca networks from a medical anthropology perspective. International Journal of Drug Policy 39:28–36. doi:10.1016/j.drugpo.2016.07.011.
  • Barbosa, P. C., S. Mizumoto, M. P. Bogenschutz, and R. J. Strassman. 2012. Health status of ayahuasca users. Drug Testing and Analysis 4 (7–8):601–09. doi:10.1002/dta.1383.
  • Barbosa, P. C., R. J. Strassman, D. X. Da Silveira, K. Areco, R. Hoy, J. Pommy, R. Thoma, and M. P. Bogenschutz. 2016. Psychological and neuropsychological assessment of regular hoasca users. Comprehensive Psychiatry 71:95–105. doi:10.1016/j.comppsych.2016.09.003.
  • Barbosa, P. C., L. F. Tófoli, M. P. Bogenschutz, R. Hoy, L. F. Berro, E. A. V. Marinho, K. N. Areco, and M. J. Winkelman. 2018. Assessment of alcohol and tobacco use disorders among religious users of ayahuasca. Frontiers in Psychiatry 9:136. doi:10.3389/fpsyt.2018.00136.
  • Bell, H. M. 1962. Bell adjustment inventory: Revised 1962 student form. Palo Alto, CA: Consulting Psychologists Press.
  • Berkman, L. F. 1995. The role of social relations in health promotion. Psychosomatic Medicine 57 (3):245–54.
  • Bouso, J. C., D. González, S. Fondevila, M. Cutchet, X. Fernández, P. C. Barbosa, M. A. Alcázar-Córcoles, W. S. Araújo, M. J. Barbanoj, J. M. Fábregas, et al. 2012. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: A longitudinal study. PLoS One 7 (8):e42421. doi:10.1371/journal.pone.0042421.
  • Bouso, J. C., F. Palhano-Fontes, A. Rodríguez-Fornells, S. Ribeiro, R. Sanches, J. A. Crippa, J. E. Hallak, D. B. de Araujo, and J. Riba. 2015. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. European Neuropsychopharmacology 25 (4):483–92. doi:10.1016/j.euroneuro.2015.01.008.
  • Bouso, J. C., and J. Riba. 2014. Ayahuasca and the treatment of drug addiction. In The therapeutic use of ayahuasca, edited by B. C. Labate and C. Cavnar, 95–109. Berlin, GE: Springer-Verlag.
  • Carhart-Harris, R. L., L. Roseman, E. Haijen, D. Erritzoe, R. Watts, I. Branchi, and M. Kaelen. 2018. Psychedelics and the essential importance of context. Journal of Psychopharmacology 32 (7):725–31. doi:10.1177/0269881118754710.
  • Carver, C. S., M. F. Scheier, and J. K. Weintraub. 1989. Assessing coping strategies: A theoretically based approach. Journal of Personality and Social Psychology 56:267–283. doi:10.1037/0022-3514.56.2.267.
  • Cavnar, C. 2014. The effects of ayahuasca ritual participation on gay and lesbian identity. Journal of Psychoactive Drugs 46 (3):252–60. doi:10.1080/02791072.2014.920117.
  • Centro de Investigaciones Sociológicas (CIS). 2017. Barómetro de marzo 2017. Accessed October 23, 2018. http://www.cis.es/cis/opencm/ES/1_encuestas/estudios/ver.jsp?estudio=14333.
  • CONECTA. 2018. Hábitos de lectura y venta de libros en España. Accessed October 23, 2018. https://fomentodelalectura.mecd.gob.es/actualidad/noticias/Bar-metro-2017.html.
  • Congreso Nacional del Medio Ambiente (CONAMA). 2016. Movilidad al trabajo. Accessed October 23, 2018. http://www.conama.org/conama/download/files/conama2016/GTs%202016/5_preliminar.pdf.
  • Danforth, A. L., C. S. Grob, C. Struble, A. A. Feduccia, N. Walker, L. Jerome, B. Yazar-Klosinski, and A. Emerson. 2018. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: A randomized, double-blind, placebo-controlled pilot study. Psychopharmacology 235 (11):3137–48. doi:10.1007/s00213-018-5010-9.
  • Dos Santos, R. G., J. C. Bouso, M. A. Alcázar-Córcoles, and J. E. Hallak. 2018. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: A systematic review of systematic reviews. Expert Review of Clinical Pharmacology 11 (9):889–902. doi:10.1080/17512433.2018.1511424.
  • Dos Santos, R. G., J. C. Bouso, and J. E. Hallak. 2016. The antiaddictive effects of ibogaine: A systematic literature review of human studies. Journal of Psychedelic Studies 1 (1):20–28. doi:10.1556/2054.01.2016.001.
  • Dos Santos, R. G., J. C. Bouso, and J. E. Hallak. 2017. Ayahuasca, dimethyltryptamine, and psychosis: A systematic review of human studies. Therapeutic Advances in Psychopharmacology 7 (4):141–57. doi:10.1177/2045125316689030.
  • Encuesta de salud del País Vasco (ESCAV). 2018. Accessed April 16, 2018. http://www.eustat.eus/comun/ExtractorBlob.ashx?id=/document/datos/cuestionarios/cuest_familiar_enc_salud_2017_c.pdf.
  • Encuesta Nacional de Salud de España (ENSE). 2017. Accessed October 23, 2018. https://www.mscbs.gob.es/estadEstudios/estadisticas/encuestaNacional/encuesta2017.htm.
  • Eurostat. 2016. Culture statistics. Accessed May 16, 2018. https://ec.europa.eu/eurostat/web/products-statistical-books/-/KS-04-15-737.
  • Fábregas, J. M., D. González, S. Fondevila, M. Cutchet, X. Fernández, P. C. Barbosa, M. A. Alcázar-Córcoles, M. J. Barbanoj, J. Riba, and J. C. Bouso. 2010. Assessment of addiction severity among ritual users of ayahuasca. Drug and Alcohol Dependence 111 (3):257–61. doi:10.1016/j.drugalcdep.2010.03.024.
  • Fedea. 2014. El sistema de salud en España en perspectiva comparada. Accessed October 23, 2018. http://www.easp.es/crisis-salud/busqueda/resultados/item/1525-el-sistema-de-salud-en-espana-en-perspectiva-comparad.
  • Fibiger, H. C. 2012. Psychiatry, the pharmaceutical industry, and the road to better therapeutics. Schizophrenia Bulletin 38 (4):649–50. doi:10.1093/schbul/sbs073.
  • Franquesa, A., A. Sainz-Cort, S. Gandy, J. Soler, M. A. Alcázar-Córcoles, and J. C. Bouso. 2018. Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach. Psychiatry Research 264:334–39. doi:10.1016/j.psychres.2018.04.012.
  • Goldberg, D. 1972. The detection of psychiatric illness by questionnaire. London, UK: Oxford University Press.
  • Grob, C. S., D. J. McKenna, J. C. Callaway, G. S. Brito, E. S. Neves, G. Oberlaender, O. L. Saide, E. Labigalini, C. Tacla, C. T. Miranda, et al. 1996. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. Journal of Nervous Mental Disorders 184 (2):86–94. doi:10.1097/00005053-199602000-00004.
  • Gross National Survey of Bhutan. 2018. Accessed May 16, 2018. https://www.grossnationalhappiness.com/.
  • Halpern, J. H., A. R. Sherwood, J. I. Hudson, D. Yurgelun-Todd, and H. G. Pope Jr. 2005. Psychological and cognitive effects of long-term peyote use among native Americans. Biological Psychiatry 58 (8):624–31. doi:10.1016/j.biopsych.2005.06.038.
  • Halpern, J. H., A. R. Sherwood, T. Passie, K. C. Blackwell, and A. J. Ruttenber. 2008. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Medical Science Monitor 14 (8):SR15–22.
  • Hartogsohn, I. 2016. Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. Journal of Psychopharmacology 30 (12):1259–67. doi:10.1177/0269881116677852.
  • Hendricks, P. S., C. B. Thorne, C. B. Clark, D. W. Coombs, and M. W. Johnson. 2015. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology 29 (3):280–88. doi:10.1177/0269881114565653.
  • Horák, M., L. Hasíková, and N. Verter. 2018. Therapeutic potential ascribed to ayahuasca by users in the Czech Republic. Journal of Psychoactive Drugs 30:1–7.
  • Hyman, S. 2012. Revolution stalled. Science Translational Medicine 4 (155). doi:10.1126/scitranslmed.3003142.
  • INEBase. 2014. Instituto Nacional de Estadística. Encuesta europea de salud en España. Madrid, Spain.
  • INEBase. 2016. Instituto Nacional de Estadística. Estadística del padrón continuo a 1 de enero de 2016. Datos a nivel nacional, comunidad autónoma y provincia. Accessed October 23, 2018. http://www.ine.es/jaxi/Datos.htm?path=/t20/e245/p04/a2016/l0/&file=00000001.px.
  • INEBase. 2017. Instituto Nacional de Estadística. Hogares por dificultades para llegar a fin de mes y tipo de hogar. Accessed October 23, 2018. http://www.ine.es/jaxiT3/Datos.htm?t=9992.
  • Insel, T. R., V. Voon, J. S. Nye, V. J. Brown, B. M. Altevogt, E. T. Bullmore, G. M. Goodwin, R. J. Howard, D. J. Kupfer, G. Malloch, et al. 2013. Innovative solutions to novel drug development in mental health. Neuroscience and Biobehavioral Reviews 37 (10Pt1):2438–44. doi:10.1016/j.neubiorev.2013.03.022.
  • Johansen, P. Ø., and T. S. Krebs. 2015. Psychedelics not linked to mental health problems or suicidal behaviour: A population study. Journal of Psychopharmacology 29 (3):270–79. doi:10.1177/0269881114568039.
  • Johnson, M. W., W. Richards, and R. R. Griffiths. 2008. Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology 22 (6):603–20. doi:10.1177/0269881108093587.
  • Jones, J., and J. Wilsdon. 2018. The biomedical bubble. Why UK research and innovation needs a greater diversity of priorities, politics, places and people. NESTA. https://www.nesta.org.uk/report/biomedical-bubble/.
  • Kavenská, V., and H. Simonová. 2015. Ayahuasca tourism: Participants in shamanic rituals and their personality styles, motivation, benefits and risks. Journal of Psychoactive Drugs 47 (5):351–59. doi:10.1080/02791072.2015.1094590.
  • Kotler, S. 2010. The new psychedelic renaissance. Playboy 50 (2):114–19.
  • Krebs, T. S., and P. Ø. Johansen. 2013. Psychedelics and mental health: A population study. PLoS One 8 (8):e63972. doi:10.1371/journal.pone.0063972.
  • Labate, B. C. 2004. A reinvenção do uso da ayahuasca nos centros urbanos. Campinas, SP: Mercado de Letras.
  • Lawn, W., J. E. Hallak, J. A. Crippa, R. G. Dos Santos, L. Porffy, M. J. Barratt, J. A. Ferris, A. R. Winstock, and C. J. A. Morgan. 2017. Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: A large, international, self-selecting online survey. Science Reports 7 (1):15201. doi:10.1038/s41598-017-14700-6.
  • Lluch, M. T. 2000. Construcción de una escala para evaluar la salud mental positiva. PhD diss., Universidad de Barcelona.
  • Luna, L. E. 2011. Indigenous and mestizo use of ayahuasca: An overview. In The ethnopharmacology of ayahuasca, ed. R. G. Dos Santos, 1–21. Kerala, India: Transworld Research Network.
  • MacRae, E. 1998. Guiado por la luna. Shamanismo y uso ritual de la ayahuasca en el culto del Santo Daime. Quito, EC: Abya-Yala.
  • Malcolm, B. J., and K. C. Lee. 2018. Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness? Mental Health Clinician 7 (1):39–45. doi:10.9740/mhc.2017.01.039.
  • McKenna, D. J. 2004. Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges. Pharmacology Therapeutics 102 (2):111–19. doi:10.1016/j.pharmthera.2004.03.002.
  • McKenna, D. J., G. H. Towers, and F. Abbott. 1984. Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and beta-carboline constituents of ayahuasca. Journal of Ethnopharmacology 10 (2):195–223.
  • Mithoefer, M. C., C. S. Grob, and T. D. Brewerton. 2016. Novel psychopharmacological therapies for psychiatric disorders: Psilocybin and MDMA. Lancet Psychiatry 3 (5):481–88. doi:10.1016/S2215-0366(15)00576-3.
  • Moscati, A., and B. Mezuk. 2014. Losing faith and finding religion: Religiosity over the life course and substance use and abuse. Drug and Alcohol Dependence 136:127–34. doi:10.1016/j.drugalcdep.2013.12.018.
  • Nichols, D. E., M. W. Johnson, and C. D. Nichols. 2017. Psychedelics as medicines: An emerging new paradigm. Clinical Pharmacology and Therapeutics 101 (2):209–19. doi:10.1002/cpt.557.
  • Nunes, A. A., R. G. Dos Santos, F. L. Osório, R. F. Sanches, J. A. Crippa, and J. E. Hallak. 2016. Effects of ayahuasca and its alkaloids on drug dependence: A systematic literature review of quantitative studies in animals and humans. Journal of Psychoactive Drugs 48 (3):195–205. doi:10.1080/02791072.2016.1188225.
  • Observatori de Salut de la Generalitat (OSG). 2014. Prevalencia de enfermedad o problema de salud crónico. Accessed October 23, 2018. http://observatorisalut.gencat.cat/es/detalls/article/08_IND_prevalenca_malaltia_problema_salut_cronic.
  • Observatorio Español de las Drogas y las Adicciones (OEDA). 2017. Informe 2017 alcohol, tabaco y drogas ilegales en España. Accessed October 23, 2018. http://www.pnsd.msssi.gob.es/profesionales/sistemasInformacion/informesEstadisticas/pdf/2017OEDA-INFORME.pdf.
  • Ona, G., and J. C. Bouso. 2019. Can psychedelics be the treatment for the crisis in psychopharmacology? Preprints, 2019010249.
  • Ozbay, F., D. C. Johnson, E. Dimoulas, C. A. Morgan, D. Charney, and S. Southwick. 2007. Social support and resilience to stress: From neurobiology to clinical practice. Psychiatry (Edgmont) 4 (5):35–40.
  • Prat, J., M. Anguera, F. Cuadet, D. Dittwald, J. Reche, I. Tomas, and I. Vivancos. 2012. Els nous imaginaris culturals. Espiritualitats orientals, terapies naturals i sabers esotèrics. Tarragona, ES: Publicaciones URV.
  • Rocha, K. B., K. Pérez, M. Rodríguez-Sans, C. Borrell, and J. E. Obiols. 2011. Propiedades psicométricas y valores normativos del General Health Questionnaire (GHQ-12) en población general española. International Journal of Clinical and Health Psychology 11 (1):125–39.
  • Ryff, C. D. 1989. Happiness is everything, or is it? Explorations on the meaning of psychological well- being. Journal of Personality and Social Psychology 57:1069–81. doi:10.1037/0022-3514.57.6.1069.
  • Ryff, C. D., and C. L. Keyes. 1995. The structure of psychological well-being revisited. Journal of Personality and Social Psychology 69:719–27. doi:10.1037/0022-3514.69.4.719.
  • Sabucedo, P. 2017. The psychological flexibility model from a cultural perspective: An interpretative analysis of two native American healing rituals. International Journal of Culture and Mental Health 10 (4):367–75. doi:10.1080/17542863.2017.1323935.
  • Sánchez, C., and J. C. Bouso. 2015. Ayahuasca: From the Amazon to the global village. Drug Policy Briefing 43. Transnational Institute. https://www.tni.org/files/publication-downloads/dpb_43_eng_web_19122015.pdf.
  • Schultes, R. E. 1967. The place of ethnobotany in the ethnopharmacologic search for psychotomimetic drugs. In Ethnopharmacologic search for psychoactive drugs. Proceedings of a symposium held in San Francisco, California, January 28–30, 1967, edited by. D. H. Efron, 33–59. Washington, DC: US Department of Health, Education, and Welfare.
  • Sessa, B. 2018. The 21st century psychedelic renaissance: Heroic steps forward on the back of an elephant. Psychopharmacology 235 (2):551–60. doi:10.1007/s00213-017-4713-7.
  • Sherbourne, C., and A. Stewart. 1991. The MOS social support survey. Social Science and Medicine 32:705–14. doi:10.1016/0277-9536(91)90150-B.
  • Sociedad Española de Neurología (SEN). 2016. Entre un 20 y un 48% de la población adulta española sufre dificultad para iniciar o mantener el sueño. Accessed October 23, 2018. http://www.sen.es/saladeprensa/pdf/Link182.pdf.
  • Sociedad Española para el Estudio de la Obesidad (SEEDO). 2018. Accessed October 23, 2018. https://www.seedo.es/.
  • Statistics Canada. 2018. Aboriginal peoples. Key indicators. Accessed May 16, 2018. https://www150.statcan.gc.ca/n1/en/subjects/aboriginal_peoples.
  • Talin, P., and E. Sanabria. 2017. Ayahuasca’s entwined efficacy: An ethnographic study of ritual healing from ‘addiction’. International Journal of Drug Policy 44:23–30. doi:10.1016/j.drugpo.2017.02.017.
  • Tobin, D. L., K. A. Holroyd, and R. V. C. Reynolds. 1984. User’s manual for the coping strategies inventory. Athens, OH: Ohio University, Department of Psychology.
  • Trompetter, H. R., P. M. Ten Klooster, K. M. G. Schreurs, M. Fledderus, G. J. Westerhof, and E. T. Bohlmeijer. 2013. Measuring values and committed action with the engaged living scale (ELS): Psychometric evaluation in a nonclinical sample and a chronic pain sample. Psychological Assessment 25 (4):1235–46. doi:10.1037/a0033813.
  • Tupper, K. W., and B. C. Labate. 2014. Ayahuasca, psychedelic studies and health sciences: The politics of knowledge and inquiry into an Amazonian plant brew. Current Drug Abuse Reviews 7 (2):71–80.
  • Van Amsterdam, J., D. Nutt, L. Phillips, and W. van Den Brink. 2015. European rating of drug harms. Journal of Psychopharmacology 29 (6):655–60. doi:10.1177/0269881115581980.
  • Wang, J., F. Mann, B. Lloyd-Evans, R. Ma, and S. Johnson. 2018. Associations between loneliness and perceived social support and outcomes of mental health problems: A systematic review. BMC Psychiatry 18 (1):156. doi:10.1186/s12888-018-1736-5.
  • Zimet, G. D., N. W. Dahlem, S. G. Zimet, and G. K. Farley. 1988. The multidimensional scale of perceived social support. Journal of Personality Assessment 52 (1):30–41. doi:10.1207/s15327752jpa5201_2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.